[Examination of occupational exposure to medical staff (primarily nurses) during 131I medical treatments].
Recently, a new amendment to protect against radiation damage to humans has been enacted based on a 1990 recommendation by the ICRP. Consequently, the dose limits of occupational exposure to medical staff were cut down sharply compared with conventional readjustments. This amended bill, however, may be triggering a reduction in the number of applicants, which hope to engage in radiotherapy. This being the case, we measured the dose levels of the occupational exposure to medical staff (doctor's group, nuclear medicine technologist's group, nurse's group and pharmacist's group) from 1999 to 2002. Moreover, we investigated what the main factor is in nurse's occupational exposure to 131I. The highest doses of occupational exposure were 3.640 mSv to doctors, 7.060 mSv to nuclear medicine technologists, 1.486 mSv to nurses and 0.552 mSv to pharmacists. According to our results, it was clear that the highest doses in each group were far below the legally mandated upper limits of exposure doses. Although we investigated the correlations between the factors of nurse's occupational exposure to 131I with the number of inpatients, the amount of 131I and the number of servicing times for patients, there were no correlations found. Furthermore, to analyzing the factors in detail, it became clear that the main factor in the nurse's occupational exposure was due to the existence of patients who needed many more servicing times for their care than ordinary patients.
Watanabe
Masayoshi
M
Ito Hospital.
Ishikawa
Naofumi
N
Ito
Kunihiko
K
Ito
Koichi
K
D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects* / Q000627:therapeutic use; D007564:Japan / Q000453:epidemiology; D009726:Nurses; D016273:Occupational Exposure / Q000032:analysis*; D011829:Radiation Dosage; D011834:Radiation Monitoring; D011835:Radiation Protection; D011872:Radiology Department, Hospital / Q000706:statistics & numerical data*; D019275:Radiopharmaceuticals / Q000009:adverse effects* / Q000627:therapeutic use
D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals